Latest Breaking News On - Filgotinib jyseleca - Page 1 : comparemela.com

Filgotinib Reduces Flare Risk in Uveitis in Phase 2 Study

Phase 2 data on filgotinib show a reduction in risk of flare in patients with uveitis and good tolerance in one of the first studies of a JAK inhibitor in uveitis.

United kingdomRobin besuyenFilgotinib jyselecaXenofon baraliakosGilead sciencesEuropean unionDrug administrationRuhr university bochum germanyInternational congress on spondyloarthritidesInternational congressRuhr university bochumDouble blind trialVery fewTreatment failure favored filgotinibIntraocular inflammationRheumatoid arthritis

New cancer drugs approved for use by NHS Scotland

New cancer drugs approved for use by NHS Scotland
pressandjournal.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressandjournal.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomFilgotinib jyselecaSelpercatinib retsevmoPembrolizumab keytrudaMark macgregorDavid fergusonCancer research united kingdomScottish medicines consortium

New cancer drugs approved for use by NHS Scotland

New cancer drugs approved for use by NHS Scotland
eveningexpress.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eveningexpress.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomFilgotinib jyselecaSelpercatinib retsevmoPembrolizumab keytrudaMark macgregorDavid fergusonCancer research united kingdomScottish medicines consortium

New cancer drugs approved for use by NHS Scotland

New cancer drugs approved for use by NHS Scotland
eveningtelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eveningtelegraph.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomFilgotinib jyselecaSelpercatinib retsevmoPembrolizumab keytrudaMark macgregorDavid fergusonCancer research united kingdomScottish medicines consortium